Company Details
|
|
Address
|
33 St. James's Square, London, SW1Y 4JS
|
|
Telephone
|
020 3008 4960
|
|
Fax
|
020 3008 4731
|
Executives
|
|
Chairman
|
Lindsay Sanford (2.90% holding)
|
|
Chief Executive
|
(0.00% holding)
|
|
Finance Director
|
Michael Acheson (0.00% holding)
|
|
Non-Exec Director
|
Jeremy Friedlander (1.00% holding)
|
Main Shareholders
|
|
|
Eastland Technology Australia: 9.2% John Butler: 5.3% Matthew Root: 5.3% Alan Frame: 4.6%
|
Advisers
|
|
Nominated Adviser
|
Shore Capital
|
|
Nominated Broker
|
Shore Capital
|
|
Solicitors
|
Pritchard Englefield
|
|
Auditors
|
Shipleys
|
|
Registrar
|
Share Registrars
|
|
Commentary
|
|
Medical supply company targeting the medical consumables, cardiorespiratory, acute and aged care markets
|
Company Data |
| Code |
INT |
| Sedol |
GB00B035PZ |
| Shares In Issue |
334.030 m |
| Indices
|
Aim |
| Entry on AIM |
27/10/2004 |
| Interim Results |
May |
| Final Results |
Oct |
| Year End |
Aug |
| Accounts Due |
Nov |
| Int div payment |
n/a |
| Fin div payment |
n/a |
| Int net div per share |
nil |
| Fin net div per share |
nil |
| Probable CGT relief |
Yes |
| |
|
|